The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
An EP2 receptor-selective prostaglandin E2agonist induces bone healing
Open accessAbstract
The morbidity and mortality associated with impaired/delayed fracture healing remain high. Our objective was to identify a small nonpeptidyl molecule with the ability to promote fracture healing and prevent malunions. Prostaglandin E 2(PGE 2) causes significant increases in bone mass and bone strength when administered systemically or locally to the skeleton. However, due to side effects, PGE 2 is an unacceptable therapeutic option for fracture healing. PGE 2 mediates its tissue-specific pharmacological activity via four different G protein-coupled receptor subtypes, EP1, -2, -3, and -4. The anabolic action of PGE 2 in bone has been linked to an elevated level of cAMP, thereby implicating the EP2 and/or EP4 receptor subtypes in bone formation. We identified an EP2 selective agonist, CP-533,536, which has the ability to heal canine long bone segmental and fracture model defects without the objectionable side effects of PGE 2, suggesting that the EP2 receptor subtype is a major contributor to PGE 2's local bone anabolic activity. The potent bone anabolic activity of CP-533,536 offers a therapeutic alternative for the treatment of fractures and bone defects in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Cited by
Bone Tissue Engineering: Recent Advances and Challenges
Amini, A. R., Laurencin, C. T., & Nukavarapu, S. P. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i5.10 · Cited by 2,336
Promoting tissue regeneration by modulating the immune system
Julier, Z., Park, A. J., Briquez, P. S., & Martino, M. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.056 · Cited by 766
Carano, R. A. D., & Filvaroff, E. H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02866-6 · Cited by 746
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
Li, F., Huang, Q., Chen, J., Peng, Y., Roop, D. R., Bedford, J. S., & Li, C.-Y. (2010) · Science Signaling · doi:10.1126/scisignal.2000634 · Cited by 494
Metadata
- Authors
- Paralkar, V. M., Borovecki, F., Ke, H. Z., Cameron, K. O., Lefker, B., Grasser, W. A., Owen, T. A., Li, M., DaSilva-Jardine, P., Zhou, M., Dunn, R. L., Dumont, F., Korsmeyer, R., Krasney, P., Brown, T. A., Plowchalk, D., Vukicevic, S., & Thompson, D. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-05-14
- Volume
- 100
- Issue
- 11
- Pages
- 6736-6740
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2108783581
- Cited by
- 183
- References
- 1
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An EP2 receptor-selective prostaglandin E2agonist induces bone healing. https://app.cochat.ai/papers/10.1073/pnas.1037343100
- The paper
- Paralkar, V. M., Borovecki, F., Ke, H. Z., Cameron, K. O., Lefker, B., Grasser, W. A., Owen, T. A., Li, M., DaSilva-Jardine, P., Zhou, M., Dunn, R. L., Dumont, F., Korsmeyer, R., Krasney, P., Brown, T. A., Plowchalk, D., Vukicevic, S., & Thompson, D. D. (2003). An EP2 receptor-selective prostaglandin E2agonist induces bone healing. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1037343100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.